Holen Sie sich die Stockscreener-App
226.42
0.17%
0.38
Handel nachbörslich:
226.42
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BDX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$226.04
Offen:
$224.77
24-Stunden-Volumen:
1.63M
Relative Volume:
0.88
Marktkapitalisierung:
$66.11B
Einnahmen:
$20.64B
Nettoeinkommen (Verlust:
$1.73B
KGV:
37.61
EPS:
6.02
Netto-Cashflow:
$2.94B
1W Leistung:
-0.69%
1M Leistung:
+0.39%
6M Leistung:
-5.56%
1J Leistung:
-6.06%
1-Tages-Spanne:
$223.54
$226.80
1-Wochen-Bereich:
$223.54
$230.95
52-Wochen-Spanne:
$218.75
$251.99
Becton Dickinson Co Stock (BDX) Company Profile
Firmenname
Becton Dickinson Co
Sektor
Telefon
(201) 847-6800
Adresse
ONE BECTON DR, FRANKLIN LAKES
Vergleichen Sie BDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
226.42 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ISRG
Intuitive Surgical Inc
|
507.05 | 177.83B | 8.35B | 2.32B | 1.30B | 6.41 |
|
ALC
Alcon Inc
|
92.59 | 45.80B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
223.00 | 32.66B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
33.65 | 17.26B | 17.28B | 108.00M | 391.00M | 0.20 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-07-24 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-05-05 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-12-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-07-11 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-06-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | Fortgesetzt | Raymond James | Mkt Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-12-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-06-01 | Fortgesetzt | Goldman | Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-07 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-02-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-01-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-05-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-12-07 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-06-21 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-04-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-01-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-01-05 | Hochstufung | Citigroup | Sell → Neutral |
| 2018-01-05 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2017-12-29 | Bestätigt | Deutsche Bank | Buy |
Alle ansehen
Becton Dickinson Co Aktie (BDX) Neueste Nachrichten
Report: BD is in talks with competitors to sell Life Sciences biz - MassDevice
Becton Dickinson in talks with Thermo Fisher, Danaher to divest life sciences unit, FT reports - MarketScreener
Becton Dickinson in talks to divest life sciences unit, FT reports - MarketScreener
Becton Dickinson In Talks With Rivals Over Divesting Life Sciences Unit- FT - MarketScreener
Becton Dickinson in talks with rivals over divesting life sciences unit - Financial Times
BD Named One of America's Most Innovative Companies by Fortune - MarketScreener
Providence Capital Advisors LLC Buys 8,230 Shares of Becton, Dickinson and Company (NYSE:BDX) - MarketBeat
Becton Dickinson Could Be Cure To Demand For Medtech Supplies, With Robust Pipeline - Seeking Alpha
BD to acquire Bard - The Covington News
Here’s What Positions Becton, Dickinson and Company (BDX) Favorably in the Health Care Sector - Yahoo Finance
Becton, Dickinson and Company Target of Unusually High Options Trading (NYSE:BDX) - MarketBeat
BD Names Gregory J. Hayes to Board of Directors - Quantisnow
BD Names Gregory J. Hayes to Board of Directors – Company Announcement - Financial Times
Goldman Sachs Adjusts PT on Becton Dickinson and Co. to $256 From $253, Keeps Buy Rating - Marketscreener.com
Goldman Sachs Adjusts PT to Becton Dickinson and Co. to $256 From $253, Keeps Buy Rating - MarketScreener
Was Jim Cramer Right About Becton, Dickinson and Company (BDX)? - Insider Monkey
Insider Sell: Richard Byrd Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus.com
FDA tags Becton, Dickinson and Company infusion software recall as Class I - Yahoo Finance
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Becton Dickinson and : BD Announces Results for 2019 Second Fiscal Quarter; Updates Fiscal 2019 Guidance - MarketScreener
Becton, Dickinson Treats First Breast Revision Patient in GalaFlex Lite Scaffold Trial -March 20, 2025 at 07:56 am EDT - MarketScreener
BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE™ Scaffold in Breast Implant Revision Surgery - Quantisnow
Becton, Dickinson and Company Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE? Scaffold in Breast Implant Revision Surgery - Marketscreener.com
Becton Dickinson EVP Richard Byrd sells $105,570 in stock By Investing.com - Investing.com Australia
Becton Dickinson EVP Richard Byrd sells $105,570 in stock - Investing.com
SEC Form 144 filed by Becton Dickinson and Company - Quantisnow
Here's Why Becton Dickinson (BDX) is a Strong Momentum Stock - Yahoo Finance
How Do Investors Really Feel About Becton Dickinson? - Benzinga
Blood Typing Analysis Report 2024: Market Set to Surge to $6.50 Billion by 2034, PCR and Microarray Techniques Pave the Way - GlobeNewswire Inc.
Becton, Dickinson, And Company Stock: Is BDX Underperforming The Healthcare Sector? - Barchart.com
Becton, Dickinson, and Company Stock: Is BDX Underperforming the Healthcare Sector? - Inkl
Becton, Dickinson and Company (NYSE:BDX) Stock Price Down 0.3% Following Insider Selling - Defense World
Becton Dickinson EVP Richard Byrd sells $436,325 in stock By Investing.com - Investing.com South Africa
Becton Dickinson EVP Richard Byrd sells $436,325 in stock - Investing.com India
Becton Dickinson Says Ex-Exec Broke Non-Compete, Stole Secrets - Bloomberg Law
Becton Dickinson at Barclays Conference: Strategic Medtech Shift By Investing.com - Investing.com Canada
Becton Dickinson at Barclays Conference: Strategic Medtech Shift - Investing.com
Fisher Asset Management LLC Has $202,000 Stake in Becton, Dickinson and Company (NYSE:BDX) - Defense World
Dividend Aristocrats In Focus: Becton, Dickinson & Co. - Sure Dividend
Becton, Dickinson and Company (NYSE:BDX) Upgraded at StockNews.com - Defense World
Insider Sell: Bertram Scott Sells Shares of Becton Dickinson & C - GuruFocus.com
December 2026 Options Now Available For Becton, Dickinson (BDX) - Nasdaq
Becton, Dickinson and Company (NYSE:BDX) Stock Rating Lowered by StockNews.com - Defense World
BD East Africa, Safaricom to compensate ex-staff over privacy breach - Capital FM Kenya
BD Packaging Innovations Get Under Patients’ Skin - Packaging Digest
Head to Head Contrast: Universal Media Group (OTCMKTS:UMGP) vs. Becton, Dickinson and Company (NYSE:BDX) - Defense World
Argus Adjusts Becton Dickinson and Co.'s Price Target to $270 From $290 -February 21, 2025 at 10:39 am EST - Marketscreener.com
Finanzdaten der Becton Dickinson Co-Aktie (BDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.12%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):